πŸ‡ΊπŸ‡Έ FDA
Patent

US 11136372

ApoC-II mimetic peptides

granted A61KA61K38/00A61K38/1709

Quick answer

US patent 11136372 (ApoC-II mimetic peptides) held by The United States of America as Represented by the Secretary, Dept. of Health and Human Services expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary, Dept. of Health and Human Services
Grant date
Tue Oct 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K38/00, A61K38/1709, A61K38/1722, A61K9/0019